Throughout the last three months, 15 analysts have evaluated FMC (NYSE:FMC), offering a diverse set of opinions from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Analysts have recently evaluated FMC and provided 12-month price targets. The average target is $17.2, accompanied by a high estimate of $24.00 and a low estimate of $13.00. Observing a downward trend, the current average is 43.42% lower than the prior average price target of $30.40.

Diving into Analyst Ratings: An In-Depth Exploration

The analysis of recent analyst actions sheds light on the perception of FMC by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to FMC. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.
• Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of FMC's stock. This comparison reveals trends in analysts' expectations over time.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of FMC's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on FMC analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Get to Know FMC Better

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

Financial Milestones: FMC's Journey

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Decline in Revenue: Over the 3M period, FMC faced challenges, resulting in a decline of approximately -49.11% in revenue growth as of 30 September, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -104.48%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): FMC's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -13.87%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): FMC's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -4.65%, the company may face hurdles in achieving optimal financial performance.

Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.2, caution is advised due to increased financial risk.

What Are Analyst Ratings?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

This article was generated by Benzinga's automated content engine and reviewed by an editor.